193 related articles for article (PubMed ID: 16750795)
1. The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients.
Cohen SP; Verdolin MH; Chang AS; Kurihara C; Morlando BJ; Mao J
J Pain; 2006 Jun; 7(6):391-8. PubMed ID: 16750795
[TBL] [Abstract][Full Text] [Related]
2. An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain.
Cohen SP; Wang S; Chen L; Kurihara C; McKnight G; Marcuson M; Mao J
J Pain Symptom Manage; 2009 Apr; 37(4):698-708. PubMed ID: 18789637
[TBL] [Abstract][Full Text] [Related]
3. The intravenous ketamine test: a predictive response tool for oral dextromethorphan treatment in neuropathic pain.
Cohen SP; Chang AS; Larkin T; Mao J
Anesth Analg; 2004 Dec; 99(6):1753-1759. PubMed ID: 15562066
[TBL] [Abstract][Full Text] [Related]
4. Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects.
Staud R; Vierck CJ; Robinson ME; Price DD
J Pain; 2005 May; 6(5):323-32. PubMed ID: 15890634
[TBL] [Abstract][Full Text] [Related]
5. Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management.
Suzuki M
Curr Opin Anaesthesiol; 2009 Oct; 22(5):618-22. PubMed ID: 19535974
[TBL] [Abstract][Full Text] [Related]
6. Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial.
Noppers I; Niesters M; Swartjes M; Bauer M; Aarts L; Geleijnse N; Mooren R; Dahan A; Sarton E
Eur J Pain; 2011 Oct; 15(9):942-9. PubMed ID: 21482474
[TBL] [Abstract][Full Text] [Related]
7. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
Finkel JC; Pestieau SR; Quezado ZM
J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
[TBL] [Abstract][Full Text] [Related]
8. Ketamine potentiates analgesic effect of morphine in postoperative epidural pain control.
Wong CS; Liaw WJ; Tung CS; Su YF; Ho ST
Reg Anesth; 1996; 21(6):534-41. PubMed ID: 8956390
[TBL] [Abstract][Full Text] [Related]
9. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain.
Rabben T; Øye I
Eur J Pain; 2001; 5(3):233-40. PubMed ID: 11558979
[TBL] [Abstract][Full Text] [Related]
10. Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia.
Klepstad P; Borchgrevink PC
Acta Anaesthesiol Scand; 1997 Mar; 41(3):422-6. PubMed ID: 9113190
[TBL] [Abstract][Full Text] [Related]
11. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
Lauterbach EC
Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats.
Plesan A; Hedman U; Xu XJ; Wiesenfeld-Hallin Z
Anesth Analg; 1998 Apr; 86(4):825-9. PubMed ID: 9539609
[TBL] [Abstract][Full Text] [Related]
13. A reconsideration of the relevance of systemic low-dose ketamine to the pathophysiology of fibromyalgia.
Wood PB
J Pain; 2006 Sep; 7(9):611-4. PubMed ID: 16942946
[TBL] [Abstract][Full Text] [Related]
14. The promise of N-methyl-D-aspartate receptor antagonists in fibromyalgia.
Henriksson KG; Sörensen J
Rheum Dis Clin North Am; 2002 May; 28(2):343-51. PubMed ID: 12122922
[TBL] [Abstract][Full Text] [Related]
15. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
Rabben T; Skjelbred P; Oye I
J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
[TBL] [Abstract][Full Text] [Related]
16. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
Grande LA; O'Donnell BR; Fitzgibbon DR; Terman GW
Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
[TBL] [Abstract][Full Text] [Related]
17. Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine).
Lemming D; Sörensen J; Graven-Nielsen T; Lauber R; Arendt-Nielsen L; Gerdle B
Eur J Pain; 2007 Oct; 11(7):719-32. PubMed ID: 17197214
[TBL] [Abstract][Full Text] [Related]
18. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
[TBL] [Abstract][Full Text] [Related]
19. Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study.
Weinbroum AA; Gorodetzky A; Nirkin A; Kollender Y; Bickels J; Marouani N; Rudick V; Meller I
Cancer; 2002 Sep; 95(5):1164-70. PubMed ID: 12209704
[TBL] [Abstract][Full Text] [Related]
20. Effect of peripheral NMDA receptor blockade with ketamine on chronic myofascial pain in temporomandibular disorder patients: a randomized, double-blinded, placebo-controlled trial.
Castrillon EE; Cairns BE; Ernberg M; Wang K; Sessle BJ; Arendt-Nielsen L; Svensson P
J Orofac Pain; 2008; 22(2):122-30. PubMed ID: 18548841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
